Evidence map›Paper›PMID 35893435›Full record

ArticleJournal of clinical medicine2022

Autoimmune Disease Classification Based on PubMed Text Mining.

Hadas Samuels, Malki Malov, Trishna Saha Detroja, Karin Ben Zaken, Naamah Bloch, Meital Gal-Tanamy, Orly Avni, Baruh Polis, Abraham O Samson

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Coenzyme Q10 and Autoimmune Disorders: An Overview.International journal of molecular sciences · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hadas SamuelsAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Malki MalovAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Trishna Saha DetrojaAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.ORCID 0000-0002-6951-956X
Karin Ben ZakenAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Naamah BlochAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Meital Gal-TanamyAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Orly AvniAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.
Baruh PolisSchool of Medicine, Yale University, New Haven, CT 06520, USA.ORCID 0000-0002-3496-8250
Abraham O SamsonAzrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.ORCID 0000-0001-7436-3515

Funding

Leir Foundation, Katz Foundation, Ginsburg foundation NA
6 · The paper itself

Abstract

Autoimmune diseases (AIDs) are often co-associated, and about 25% of patients with one AID tend to develop other comorbid AIDs. Here, we employ the power of datamining to predict the comorbidity of AIDs based on their normalized co-citation in PubMed. First, we validate our technique in a test dataset using earlier-reported comorbidities of seven knowns AIDs. Notably, the prediction correlates well with comorbidity (R = 0.91) and validates our methodology. Then, we predict the association of 100 AIDs and classify them using principal component analysis. Our results are helpful in classifying AIDs into one of the following systems: (1) gastrointestinal, (2) neuronal, (3) eye, (4) cutaneous, (5) musculoskeletal, (6) kidneys and lungs, (7) cardiovascular, (8) hematopoietic, (9) endocrine, and (10) multiple. Our classification agrees with experimentally based taxonomy and ranks AID according to affected systems and gender. Some AIDs are unclassified and do not associate well with other AIDs. Interestingly, Alzheimer's disease correlates well with other AIDs such as multiple sclerosis. Finally, our results generate a network classification of autoimmune diseases based on PubMed text mining and help map this medical universe. Our results are expected to assist healthcare workers in diagnosing comorbidity in patients with an autoimmune disease, and to help researchers in identifying common genetic, environmental, and autoimmune mechanisms.

Indexed as

Alzheimer’s diseaseautoimmune diseaseclassificationfrequency analysislist of autoimmune diseasesPubMedtaxonomytext mining

Identifiers

PMID35893435
PMCPMC9369164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.